HARBOR CAPITAL ADVISORS, INC. Allogene Therapeutics, Inc. Transaction History

HARBOR CAPITAL ADVISORS, INC. portfolio value:

$662,000
portfolio value

HARBOR CAPITAL ADVISORS, INC. quarter portfolio value change:

-5.26%
quarter

Allogene Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -31.89% -28.69K shares -364K $10.8 61.29K
Q2 2022 share Decrease -2.98% -2.76K shares 181K $11.4 89.99K
Q1 2022 share Decrease -22.41% -26.79K shares -939K $9.11 92.75K
Q4 2021 share Increase 0.00% 119.54K shares 1.78M $15.38 119.54K